Arthur Kuan is the founder of CG Oncology. CG Oncology has raised $200M in total funding. Latest round: IPO. Based in Irvine, California.
Arthur Kuan is the CEO of CG Oncology, a late-stage clinical biopharmaceutical company focused on developing a bladder-sparing therapeutic for bladder cancer. He became CEO in 2016 and has since led the company through multiple financing rounds and a successful IPO in January 2024.
Full founder directory · Investor directory · Company funding database · Fundraising library